Obesity is a well-established risk factor for postmenopausal breast cancer, and any artificial sweetener-induced changes in leptin and ghrelin levels may have implications for breast cancer risk through obesity-related mechanisms. The gene discussed is GHRL; the disease is obesity due to melanocortin 4 receptor deficiency.